首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Lancet Respiratory Medicine

Lancet Respiratory Medicine杂志,由Elsevier Ltd出版,于2013年创刊,12 issues/year,出版语言English,ISSN:2213-2600,E-ISSN:2213-2619。

投稿咨询
Lancet Respiratory Medicine
Lancet Respiratory Medicine
Lancet Respiratory Medicine
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
34.7
CiteScore
48.1
期刊收录
SCI、SCIE

Lancet Respiratory Medicine(中文译名:《柳叶刀呼吸内科》),ISSN:2213-2600,EISSN:2213-2619,是Elsevier Ltd出版的国际性学术期刊,创刊于2013年,以12 issues/year形式稳定发行,2026年总发文量约75篇。该刊采用非OA开放访问,学科归属为RESPIRATORY SYSTEM - RESPIRATORY SYSTEM。该刊是医学、危重病医学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达34.7,2025年期刊CiteScore为48.1,2025年期刊自引率约1.4%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Lancet Respiratory Medicine长期聚焦医学、危重病医学及相关产业的技术应用前沿,在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、危重病医学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Canada、GERMANY (FED REP GER)、France、Netherlands、Italy等为核心发文国家与地区;IMPERIAL COLLEGE LONDONUNIVERSITY OF LONDON、HARVARD UNIVERSITY、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、ROYAL BROMPTON HOSPITAL、UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF TORONTO等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CRITICAL CARE MEDICINE 危重病医学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 66

99.2

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 107

99.5

学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 66

99.24

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 107

99.53

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 54

99.1

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 100

99.5

学科:CRITICAL CARE MEDICINE SCIE Q1 1 / 55

99.09

学科:RESPIRATORY SYSTEM SCIE Q1 1 / 101

99.5


中国学者近期发文

1
Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trial

Author:Papi, Alberto; Wise, Robert A; Jackson, David J; Lugogo, Njira; Chen, Ruchong; Trasieva, Teodora; Obasi, Chidi; Movitz, Charlotta; Helman, Jesse; Salter, Patricia; Springer, Katarzyna; Bondoc, Marco; Shah, Mihir; Knappenberger, Katharine; Bowen, Karin; Pandya, Hitesh; Megally, Ayman; Patel, Mehul

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 4, pp. 350-362. DOI: 10.1016/S2213-2600(25)00457-6

2
Climate change and tuberculosis: an analytical framewor

Author:Saunders, Matthew J.; Boccia, Delia; Khan, Palwasha Y.; Gosce, Lara; Gasparrini, Antonio; Clark, Rebecca A.; Pescarini, Julia M.; Charalambous, Salome; Fekadu, Lelisa; Johansen, Fernanda Dockhorn Da Costa; Vasilyeva, Irina; Narendran, Gopalan; Li, Tao; Ndjeka, Norbert; White, Richard G.; Houben, Rein M. G. J.; Zignol, Matteo; Gebreselassie, Nebiat; Mcquaid, Christopher Finn

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 3, pp. 267-280. DOI: 10.1016/S2213-2600(25)00329-7

3
Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) tria

Author:Moseby-Knappe, Marion; Levin, Helena; Ullen, Susann; Zetterberg, Henrik; Blennow, Kaj; Lagebrant, Alice; Dankiewicz, Josef; Jakobsen, Janus C.; Lilja, Gisela; Nichol, Alistair D.; Eastwood, Glenn; Ainscough, Kate; Thomas, Matthew J. C.; Grejs, Anders M.; Keeble, Thomas R.; Rylander, Christian; During, Joachim; Wise, Matt P.; Hovdenes, Jan; Storm, Christian; Borgquist, Ola; Cariou, Alain; Deye, Nicolas; Lascarrou, Jean-Baptiste; Bannard-Smith, Jonathan; Unden, Johan; Vignon, Philippe; Legriel, Stephane; Smid, Ondrej; Pogson, David; Karasek, Jiri; McGuigan, Peter J.; Joannidis, Michael; Kirkegaard, Hans; Bewley, Jeremy; Christensen, Steffen; Maccaroni, Maria Rita; Valerianova, Anna; Lundin, Andreas; Lybeck, Anna; Leithner, Christoph; Varhanik, Filip; Sweet, Katie; Walden, Andrew; Friberg, Hans; Cronberg, Tobias; Nielsen, Niklas

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 3, pp. 215-224. DOI: 10.1016/S2213-2600(25)00363-7

4
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a tria

Author:Zhong, Jia; Zhao, Jun; Duan, Jianchun; Fang, Jian; Fei, Kailun; Li, Xiaoyan; Chen, Jiayan; Wang, Zhijie; Chu, Qian; Yu, Yan; Liu, Zhe; Zhang, Li; Zhao, Yanqiu; Li, Xingya; Wu, Lin; Xing, Ligang; Zhuang, Wu; Fang, Xuefeng; Chang, Jianhua; Pan, Yueyin; Dong, Xiaorong; Liu, Lian; Bai, Chunmei; Pan, Pinhua; Song, Qibin; Jin, Bo; Cao, Baoshan; Ye, Feng; Shi, Jianhua; Tang, Kejing; Wang-Gillam, Andrea; Ding, Yuli; Bi, Chao; Shao, Yang; Pang, Jiaohui; Wan, Rui; Sun, Boyang; Xu, Jiachen; Wang, Jie

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 2, pp. 163-173. DOI: 10.1016/S2213-2600(25)00258-9

5
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3tria

Author:Wang, Lin; Hao, Xuezhi; Hao, Yanrong; Hu, Yanping; Chen, Chun; Chen, Bi; Huang, Yunchao; Zang, Aimin; Wang, Yan; Chen, Zhendong; Zhuang, Wu; Shi, Jinsheng; Ren, Xiubao; Nie, Ligong; Yu, Guohua; Luo, Feng; Mao, Yimin; Wang, Xiang; Li, Baolan; Bai, Yuansong; Shi, Jianhua; Ni, Hongyan; Yu, Haoyu; Li, Jing; Wang, Qingyu; Zhu, Jun; Shi, Yuankai

Journal: LANCET RESPIRATORY MEDICINE. 2026; Vol. 14, Issue 2, pp. 117-128. DOI: 10.1016/S2213-2600(25)00263-2

6
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled tria

Author:Zhong, Nan-Shan; Qiu, Rong; Cao, Jie; Huang, Yan-Ming; Zhou, Hua; Xu, Xing-Xiang; Xu, Jin-Fu; Ye, Huan; Yang, Zhi-Ren; Gao, Ling-Yun; Shen, Yao; Xiao, Zu-Ke; Xie, Shi-Guang; Lin, Dian-Jie; Zhao, Li; Xiong, Hao; Zhang, Xian-Ming; Li, Fang-Qiong; Guan, Wei-Jie; Chalmers, James

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 5, pp. 414-424. DOI: 10.1016/S2213-2600(25)00019-0

7
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and overtime: a population-based stud

Author:Luo, Ganfeng; Zhang, Yanting; Rumgay, Harriet; Morgan, Eileen; Langselius, Oliver; Vignat, Jerome; Colombet, Murielle; Bray, Freddie

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. 348-363. DOI: 10.1016/S2213-2600(24)00428-4

8
An overview of influenza H5 vaccine

Author:Taaffe, Jessica; Zhong, Shuyi; Goldin, Shoshanna; Rawlings, Kate S.; Cowling, Benjamin J.; Zhang, Wenqing

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. e20-e21. DOI: 10.1016/S2213-2600(25)00052-9

9
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 stud

Author:Shi, Yuankai; Guo, Yanzhen; Li, Xingya; Wu, Lin; Chen, Zhaohong; Yang, Sheng; Bi, Minghong; Zhao, Yanqiu; Yao, Wenxiu; Yu, Huiqing; Yu, Huiqing; Wang, Ke; Zhao, Wenhua; Sun, Meili; Zhang, Liangming; He, Zhiyong; Lin, Yingcheng; Shi, Jianhua; Zhu, Bo; Wang, Lijun; Pan, Yueyin; Shi, Huaqiu; Sun, Shenghua; Wen, Meiling; Zhou, Rui; Guo, Shuliang; Han, Zhigang; Yi, Tienan; Zhang, Hua; Cang, Shundong; Yu, Zhuang; Zhong, Diansheng; Cui, Jiuwei; Fang, Jian; Gao, Jinghua; Li, Manxiang; Ma, Rui; Jiang, Mingyan; Qin, Jianwen; Shu, Yongqian; Ye, Feng; Hu, Sheng; Li, Wen; Lu, Hong; Yang, Minglei; Yi, Shanyong; Zhang, Yan; Fan, Yun; Ji, Hongbo; Liu, Zheng; Wang, Haitao; Zhou, Xiangdong; Zhang, Don; Peng, Jirong; Shen, Haijiao; Gao, Feng; Wang, Tingting; Zhou, Anqi

Journal: LANCET RESPIRATORY MEDICINE. 2025; Vol. 13, Issue 4, pp. 327-337. DOI: 10.1016/S2213-2600(24)00417-X


在线咨询

Lancet Respiratory Medicine

国际简称:LANCET RESP MED参考译名:柳叶刀呼吸内科

年发文量:75 CiteScore:48.1 是否预警:否 Gold OA文章占比:19.32% 研究类文章占比:92.00%

杂志社联系方式:THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Lancet Respiratory Medicine